Univercells Technologies

Associated Content

Bioreactor platform supports intensified processes to meet increasing demand for viral vaccines and viral vectors

The industry has been facing increasing capacity demand for virus production due in large part to the success and growing need for viral vaccines and viral vectors. What is the most efficient way to meet ... Continued

Addressing the need for flexible large-scale virus production with an intensified, integrated platform

The biopharmaceutical industry has experienced unprecedented growth in recent years due to approvals for novel genomic medicines and increased need for agile, scalable vaccine production capacity to respond to emerging infectious diseases. This growth has ... Continued

The scale-X™ carbo bioreactor: flexible GMP viral production at bench scale in adherent or suspension processes

Producing viral products for vaccines or cell and gene therapy starts with cell culture, where bioprocessing equipment must be selected to ensure conditions established at bench-scale can be successfully translated to the clinics and onwards. ... Continued

The NevoLine™ Upstream platform provides intensified and automated large scale virus manufacturing in a compact footprint

This system combines the principles of process intensification and chaining to provide high performance, cost-effective GMP virus manufacturing. The platform delivers commercial scale upstream manufacturing within a 3 m² system, a 3-fold reduction in equipment footprint compared to conventional technologies. Moreover, the system is especially suited to fit in modular facilities often utilized for rapid and flexible implementation of manufacturing capacity....Continued

Innovative vaccine manufacturing enables the delivery of vaccines to the developing world

In this podcast and accompanying article, we interviewed Dr. Alex Chatel, Product Manager, Viral Applications, Univercells about the biggest challenges facing vaccine manufacturing today, why it is so difficult to manufacture and deliver vaccines to the developing world and how a novel technology with the support of the Gates Foundation is poised to address these challenges....Continued